BioRegenx Files 2025 Annual Report
Ticker: BRGX · Form: 10-K · Filed: Apr 15, 2026 · CIK: 0001593184
| Field | Detail |
|---|---|
| Company | Bioregenx, INC. (BRGX) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 10-K, financials
TL;DR
BioRegenx filed its 2025 10-K. All good.
AI Summary
BioRegenx, Inc. filed its annual report on Form 10-K for the fiscal year ending December 31, 2025. The filing includes the company's financial statements, business descriptions, and certifications from its CEO and CFO. The company's principal executive offices and mailing address are located at 7407 Ziegler Road, Chattanooga, TN 37421.
Why It Matters
This 10-K filing provides a comprehensive overview of BioRegenx's financial health and operational status for the past fiscal year, offering insights for investors and stakeholders.
Risk Assessment
Risk Level: low — This filing is a standard annual report and does not contain immediate, high-impact risk disclosures.
Key Numbers
- 1054832 — iXBRL 10-K Size (Size of the interactive data document for the 10-K filing.)
- 79 — Documents (Total number of documents included in the submission.)
Key Players & Entities
- BIOREGENX, INC. (company) — Filer of the 10-K
- 0001593184 (company) — CIK number for BioRegenx, Inc.
- 2025-12-31 (date) — Period of report for the 10-K
- 2026-04-15 (date) — Filing date of the 10-K
- 7407 ZIEGLER ROAD CHATTANOOGA TN 37421 (location) — Mailing and Business Address
FAQ
What is the primary business of BioRegenx, Inc. according to the SIC code?
According to the SIC code 7370, BioRegenx, Inc. is involved in Services-Computer Programming, Data Processing, Etc.
When was the 10-K filing accepted by the SEC?
The 10-K filing was accepted on 2026-04-15 at 13:51:34.
What is the state of incorporation for BioRegenx, Inc.?
BioRegenx, Inc. is incorporated in Nevada (NV).
What is the CIK number for BioRegenx, Inc.?
The CIK number for BioRegenx, Inc. is 0001593184.
What is the fiscal year end for BioRegenx, Inc.?
The fiscal year end for BioRegenx, Inc. is December 31 (1231).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2026 regarding BIOREGENX, INC. (BRGX).